Jeff Yass’s Phathom Pharmaceuticals PHAT Stock Holding History
Bought
Maintained
Sold
Other funds holding PHAT
6CM
Jeff Yass's PHAT Position: Q3 2026 in Review
Jeff Yass increased its Phathom Pharmaceuticals (PHAT) stake by 91% in Q3 2026, buying an estimated $151K and bringing the position to 33,780 shares worth $247K. The position accounts for ﹤0.01% of the portfolio, ranked #11443.
Jeff Yass first reported a position in PHAT in Q4 2020 and has held it in 17 quarters since. The position peaked at $9.11M in Q4 2025. 159 funds tracked by Wall St. Rank hold PHAT as of Q3 2026.
- Jeff Yass held 33,780 shares of Phathom Pharmaceuticals worth $247K as of Q3 2026.
- Jeff Yass bought 16,055 Phathom Pharmaceuticals shares in Q3 2026, an estimated $151K.
- Phathom Pharmaceuticals made up ﹤0.01% of Jeff Yass's portfolio in Q3 2026, its #11443 holding.
- Jeff Yass first reported a position in Phathom Pharmaceuticals in Q4 2020 and has held it in 17 quarters since.
- Jeff Yass's Phathom Pharmaceuticals position peaked at $9.11M in Q4 2025.
- 159 funds tracked by Wall St. Rank held Phathom Pharmaceuticals as of Q3 2026.
Based on Susquehanna International Group's 13F filing for Q3 2026, filed 16 Nov 2026.